Enallylpropymal
Enallylpropymal is a barbiturate derivative that was developed in the mid-20th century. It is known for its sedative, hypnotic, and anticonvulsant properties. Enallylpropymal is chemically related to other barbiturates and shares many of their pharmacological effects.
Chemical Structure and Properties[edit | edit source]
Enallylpropymal, also known by its chemical name 5-(2-propenyl)-5-(1-propynyl)-1,3-diazinane-2,4,6-trione, is a member of the barbiturate class of drugs. The structure of enallylpropymal includes a barbituric acid core with specific substitutions that confer its unique properties.
Pharmacology[edit | edit source]
Enallylpropymal acts on the central nervous system (CNS) by enhancing the activity of the gamma-aminobutyric acid (GABA) neurotransmitter. This action results in increased inhibitory effects in the CNS, leading to sedation and hypnosis. The drug also has anticonvulsant properties, making it useful in the treatment of certain types of seizures.
Medical Uses[edit | edit source]
Enallylpropymal has been used primarily as a sedative and hypnotic agent. It has also been employed in the management of epilepsy and other seizure disorders due to its anticonvulsant effects. However, the use of enallylpropymal has declined with the development of newer medications with improved safety profiles.
Side Effects[edit | edit source]
Like other barbiturates, enallylpropymal can cause a range of side effects. Common side effects include drowsiness, dizziness, and headache. More severe side effects can include respiratory depression, hypotension, and dependence with prolonged use.
History[edit | edit source]
Enallylpropymal was first synthesized in the mid-20th century as part of efforts to develop new barbiturate derivatives with improved therapeutic profiles. It was one of many barbiturates that were investigated for their potential medical uses.
Regulation and Legal Status[edit | edit source]
Due to its potential for abuse and dependence, enallylpropymal is regulated under various national and international drug control laws. In many countries, it is classified as a controlled substance and its use is restricted to specific medical indications.
See Also[edit | edit source]
References[edit | edit source]
External Links[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD